share_log

Lifeist Closes CannMart Transaction With Simply Solventless Concentrates Ltd.

Lifeist Closes CannMart Transaction With Simply Solventless Concentrates Ltd.

Lifeist與Simply Solventless Concentrates Ltd.完成了CannMart交易。
GlobeNewswire ·  09/13 06:11

TORONTO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to support human wellness in innovative ways, is pleased to report that, further to its news release dated June 25, 2024, it has completed the sale today of the shares (the "Closing") of CannMart Inc. ("CannMart"), a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards, to Simply Solventless Concentrates Ltd. (TSXV: HASH, hereinafter "SSC"), an arm's length party, pursuant to the terms of a share purchase agreement (the "SPA") dated June 25, 2024 made between the Company, SSC and CannMart.

多倫多,2024年9月12日(環球新聞專線)——Lifeist Wellness Inc.(「Lifeist」 或 「公司」)(多倫多證券交易所股票代碼:LFST)(法蘭克福:M5B)(OTCMKTS:LFSWF)是一家利用科學和技術進步以創新方式支持人類健康的健康科技公司,很高興地報告說,繼2024年6月25日發佈的新聞稿之後,它已於今天完成了向加拿大省政府控制委員會出售休閒大麻的B20批發分銷企業CannMart Inc.(「CannMart」)股票的出售(「收盤價」)根據公司、SSC和CannMart於2024年6月25日簽訂的股票購買協議(「SPA」)的條款,獨立交易方Simply Solventless Concenterates Ltd.(多倫多證券交易所股票代碼:HASH,以下簡稱 「SSC」)。

SSC is a leading Canadian cannabis company which has successfully implemented innovative systems and operational methodologies resulting in six straight quarters of positive EBITDA and positive net income in Q1 2024.

SSC是一家領先的加拿大大麻公司,成功實施了創新的系統和運營方法,從而在2024年第一季度實現了連續六個季度的息稅折舊攤銷前利潤和正淨收入。

"We are pleased to announce the successful completion of the sale of CannMart to Simply Solventless Concentrates, a company whose track record of profitability and operational excellence has continually impressed us," said Meni Morim, CEO of Lifeist. "This transaction not only ensures that CannMart is in capable hands but also allows Lifeist to sharpen its focus on our core mission of transforming human wellness. We believe that this sale represents a strategic win for our shareholders, as it positions Lifeist to allocate more resources towards growing Mikra while still benefiting from Simply Solventless' continued success in the cannabis market."

Lifeist首席執行官梅尼·莫里姆表示:「我們很高興地宣佈,成功完成了對Simply Solventless Concenters的出售,該公司的盈利和卓越運營記錄一直給我們留下深刻的印象。」「這筆交易不僅確保了CannMart掌握在有能力的人手中,而且還使Lifeist能夠更加專注於我們改變人類健康的核心使命。我們認爲,此次出售對我們的股東來說是一次戰略勝利,因爲它使Lifeist能夠分配更多資源用於發展Mikra,同時仍然受益於Simply Solventless在大麻市場的持續成功。」

Lifeist obtained and the requisite shareholder approval to complete the sale of CannMart at its Annual General and Special Meeting held on September 5, 2024 and the approval of the TSX Venture Exchange to close the said transaction. In accordance with the terms of the SPA, as consideration for the sale of the issued and outstanding shares of CannMart to SSC, the Company received the following on the Closing:

Lifeist在2024年9月5日舉行的年度股東大會和特別會議上獲得了必要的股東批准,完成了對CannMart的出售,並獲得了多倫多證券交易所風險交易所的批准,以完成上述交易。根據SPA的條款,作爲向SSC出售CannMart已發行和流通股票的對價,公司在收盤時收到了以下信息:

  1. A cash payment in the amount of $500,000.
  2. 2,000,000 units of securities of SSC (the "Units") at a price of $0.25 per unit for a total value of $500,000. Each Unit is comprised of one common share in the capital of SSC (each, a "Common Share") and one-half of one Common Share purchase warrant. Each full warrant entitles Lifeist to purchase one SSC Common Share at an exercise price of $0.40 per Common Share for a period of 24 months following the date of issuance, subject to acceleration.
  3. a promissory note from SSC (the "VTB Loan"), secured against the assets of CannMart, in the principal amount of $1,700,000 bearing interest at the rate of 3% per annum beginning on the date of the Closing, with the principal and accrued interest repayable by SSC in monthly instalments of principal and interest, payable on the first business day of each month following the date of Closing, as follows: October 1, 2024, $100,000; November 1, 2024, $400,000; December 1, 2024, $150,000; January 1, 2025, $150,000; February 1, 2025, $150,000; March 1, 2025, $150,000, and for each month thereafter, $100,000, until fully paid.
  1. 金額爲50萬美元的現金付款。
  2. 2,000,000單位的SSC證券(「單位」),價格爲每單位0.25美元,總價值爲50萬美元。每個單位由SSC資本中的一股普通股(每股爲 「普通股」)和一半的普通股購買權證組成。每份完整認股權證均使Lifeist有權以每股普通股0.40美元的行使價購買一股SSC普通股,期限爲自發行之日起24個月,但可能有所加速。
  3. SSC的期票(「VtB貸款」),以CannMart的資產爲抵押,本金爲1700,000美元,自收盤之日起按年利率爲3%,本金和應計利息由SSC按月分期償還本金和利息,在收盤之日後的每個月的第一個工作日支付,如下所示:2024年10月1日,美元 10萬美元;2024年11月1日,40萬美元;2024年12月1日,15萬美元;2025年1月1日,15萬美元;2025年2月1日,15萬美元;2025年3月1日,15萬美元;2025年3月1日,15萬美元,以及此後每個月爲100,000美元,直至全額付清。

Furthermore, the VTB Loan is subject to an upward adjustment in an amount equal to 20% of the amount (if any) by which CannMart's quarterly gross revenue exceeds $3,000,000 in respect of CannMart's existing brands in each of the fully completed four fiscal quarters immediately following June 25, 2024.

此外,VtB貸款將向上調整,金額相當於CannMart在緊接2024年6月25日之後完全完成的四個財政季度中CannMart現有品牌的季度總收入超過300萬美元的金額(如果有)的20%。

The SPA was the result of arm's length negotiations conducted between the Company and SSC. A copy of the SPA is available for review under the Company's SEDAR+ profile at .

SPA是公司與SSC之間進行獨立談判的結果。SPA的副本可在公司的SEDAR+簡介下查看,網址爲。

About Lifeist Wellness Inc.

關於 Lifeist Wellness

Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to develop innovative products support human wellness and transform lives. Lifeist key asset is its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra"), a biosciences and consumer wellness company focused on developing and selling innovative products.

Lifeist處於疫情後健康革命的最前沿,利用科學和技術的進步來開發支持人類健康和改變生活的創新產品。Lifeist的關鍵資產是其美國生物科學子公司Mikra Cellular Sciences Inc.(「Mikra」),這是一家專注於開發和銷售創新產品的生物科學和消費者健康公司。

Information on Lifeist and its businesses can be accessed through the links below:

有關Lifeist及其業務的信息可以通過以下鏈接訪問:

Contact:
Meni Morim
CEO
Lifeist Wellness Inc.
Ph: 647-362-0390
Email: ir@lifeist.com

聯繫人:
Meni Morim
首席執行官
Lifeist健康公司
Ph: 647-362-0390
電子郵件: ir@lifeist.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任,也未以任何方式批准或不批准本新聞稿的內容。

Forward Looking Information

前瞻性信息

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen.

本新聞稿包含適用證券法所指的 「前瞻性信息」。此處包含的所有非歷史性陳述均包含前瞻性信息。前瞻性信息可以通過單詞或短語來識別,例如 「可能」、「期望」、「可能」、「應該」、「將」、「計劃」、「預期」、「打算」、「潛在」、「提議」、「估計」、「相信」 或這些術語的否定詞、表達方式和語法變體,或某些事件或條件 「可能」 或 「將」 發生的陳述。

By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release.

就其性質而言,前瞻性信息受固有的風險和不確定性的影響,這些風險和不確定性可能是一般性的,也可能是具體的,這些風險和不確定性可能導致預期、預測、預測、預測或結論不準確,假設可能不正確,目標、戰略目標和優先事項無法實現。各種因素,包括已知和未知的風險,其中許多是我們無法控制的,可能導致實際業績與本新聞稿中的前瞻性信息存在重大差異。

Additional risk factors can also be found in the Company's current MD&A filed under the Company's SEDAR+ profile at . Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

其他風險因素還可以在公司SEDAR+簡介下提交的公司當前MD&A中找到,網址爲 。提醒讀者不要過分依賴前瞻性信息。除非適用法律要求,否則公司沒有義務更新或修改任何前瞻性信息,無論是由於新信息、未來事件還是其他原因。本警示聲明明確限制了本新聞稿中包含的前瞻性陳述。

Source: Lifeist Wellness Inc.

資料來源:Lifeist Wellness


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論